Cargando…
Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype
Targeted proteasomal and autophagic protein degradation, often employing bifunctional modalities, is a new paradigm for modulation of protein function. In an attempt to explore protein degradation by means of autophagy we combine arylidene-indolinones reported to bind the autophagy-related LC3B-prot...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689823/ https://www.ncbi.nlm.nih.gov/pubmed/38036533 http://dx.doi.org/10.1038/s41467-023-43657-6 |
_version_ | 1785152430235713536 |
---|---|
author | Xue, Gang Xie, Jianing Hinterndorfer, Matthias Cigler, Marko Dötsch, Lara Imrichova, Hana Lampe, Philipp Cheng, Xiufen Adariani, Soheila Rezaei Winter, Georg E. Waldmann, Herbert |
author_facet | Xue, Gang Xie, Jianing Hinterndorfer, Matthias Cigler, Marko Dötsch, Lara Imrichova, Hana Lampe, Philipp Cheng, Xiufen Adariani, Soheila Rezaei Winter, Georg E. Waldmann, Herbert |
author_sort | Xue, Gang |
collection | PubMed |
description | Targeted proteasomal and autophagic protein degradation, often employing bifunctional modalities, is a new paradigm for modulation of protein function. In an attempt to explore protein degradation by means of autophagy we combine arylidene-indolinones reported to bind the autophagy-related LC3B-protein and ligands of the PDEδ lipoprotein chaperone, the BRD2/3/4-bromodomain containing proteins and the BTK- and BLK kinases. Unexpectedly, the resulting bifunctional degraders do not induce protein degradation by means of macroautophagy, but instead direct their targets to the ubiquitin-proteasome system. Target and mechanism identification reveal that the arylidene-indolinones covalently bind DCAF11, a substrate receptor in the CUL4A/B-RBX1-DDB1-DCAF11 E3 ligase. The tempered α, β-unsaturated indolinone electrophiles define a drug-like DCAF11-ligand class that enables exploration of this E3 ligase in chemical biology and medicinal chemistry programs. The arylidene-indolinone scaffold frequently occurs in natural products which raises the question whether E3 ligand classes can be found more widely among natural products and related compounds. |
format | Online Article Text |
id | pubmed-10689823 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-106898232023-12-02 Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype Xue, Gang Xie, Jianing Hinterndorfer, Matthias Cigler, Marko Dötsch, Lara Imrichova, Hana Lampe, Philipp Cheng, Xiufen Adariani, Soheila Rezaei Winter, Georg E. Waldmann, Herbert Nat Commun Article Targeted proteasomal and autophagic protein degradation, often employing bifunctional modalities, is a new paradigm for modulation of protein function. In an attempt to explore protein degradation by means of autophagy we combine arylidene-indolinones reported to bind the autophagy-related LC3B-protein and ligands of the PDEδ lipoprotein chaperone, the BRD2/3/4-bromodomain containing proteins and the BTK- and BLK kinases. Unexpectedly, the resulting bifunctional degraders do not induce protein degradation by means of macroautophagy, but instead direct their targets to the ubiquitin-proteasome system. Target and mechanism identification reveal that the arylidene-indolinones covalently bind DCAF11, a substrate receptor in the CUL4A/B-RBX1-DDB1-DCAF11 E3 ligase. The tempered α, β-unsaturated indolinone electrophiles define a drug-like DCAF11-ligand class that enables exploration of this E3 ligase in chemical biology and medicinal chemistry programs. The arylidene-indolinone scaffold frequently occurs in natural products which raises the question whether E3 ligand classes can be found more widely among natural products and related compounds. Nature Publishing Group UK 2023-11-30 /pmc/articles/PMC10689823/ /pubmed/38036533 http://dx.doi.org/10.1038/s41467-023-43657-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Xue, Gang Xie, Jianing Hinterndorfer, Matthias Cigler, Marko Dötsch, Lara Imrichova, Hana Lampe, Philipp Cheng, Xiufen Adariani, Soheila Rezaei Winter, Georg E. Waldmann, Herbert Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype |
title | Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype |
title_full | Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype |
title_fullStr | Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype |
title_full_unstemmed | Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype |
title_short | Discovery of a Drug-like, Natural Product-Inspired DCAF11 Ligand Chemotype |
title_sort | discovery of a drug-like, natural product-inspired dcaf11 ligand chemotype |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689823/ https://www.ncbi.nlm.nih.gov/pubmed/38036533 http://dx.doi.org/10.1038/s41467-023-43657-6 |
work_keys_str_mv | AT xuegang discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype AT xiejianing discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype AT hinterndorfermatthias discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype AT ciglermarko discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype AT dotschlara discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype AT imrichovahana discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype AT lampephilipp discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype AT chengxiufen discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype AT adarianisoheilarezaei discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype AT wintergeorge discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype AT waldmannherbert discoveryofadruglikenaturalproductinspireddcaf11ligandchemotype |